diclazuril
Small moleculeexperimental
Diclazuril is a coccidiostat. In 2025 diclazuril has also been reported to interact with tubulin and inhibit its polymerization. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00002027)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl- Mol. weight
- 407.64 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaDiclazuril ↗
- ChEMBLCHEMBL284733 ↗
Also known as
- 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)benzeneacetonitrile
- clinacox
- diclazuril
- diclazuril
- diclazuril
- r 64433
- r-64433
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00002027 | N/A | Nov 2, 1999 | Johnson and Johnson |
| NCT00002278 | N/A | Nov 2, 1999 | Johnson and Johnson |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 2 | 2 | 1 | 1999 |
1 organizations
Page 1 / 1